True NorthHealth Labs Build
Peptide Answers

compound

Ara-290 (16 mg Vial) Questions Answered

Ara-290 (also known as cibinetide) is a non-erythropoietic peptide derived from erythropoietin that engages the Innate Repair Receptor (IRR).

Read full protocol Calculate dose Find supplies TNHL ebooks
Educational reference only. TNHL does not diagnose, prescribe, or replace care from a licensed professional. Confirm all dosing, contraindications, and product decisions with qualified guidance.
Direct answer

Ara-290 (16 mg Vial)

Week Daily Dosage Units (per injection) with mL Weeks 1–4 4 mg once daily (SC) 50 units (0.50 mL) Weeks 5–12 (Optional extension) 4 mg once daily (SC) 50 units (0.50 mL) Reconstitution: Add 2.0 mL bacteriostatic water to the 16 mg vial to yield an 8 mg/mL s...

Quickstart Highlights

Ara-290 (also known as cibinetide) is a non-erythropoietic peptide derived from erythropoietin that engages the Innate Repair Receptor (IRR).

Standard / Gradual Approach (2 mL = 8 mg/mL)

Week Daily Dosage Units (per injection) with mL Weeks 1–4 4 mg once daily (SC) 50 units (0.50 mL) Weeks 5–12 (Optional extension) 4 mg once daily (SC) 50 units (0.50 mL) Reconstitution: Add 2.0 mL bacteriostatic water to the 16 mg vial to yield an 8 mg/mL s...

Potential Benefits & Side Effects

Reported findings from clinical and preclinical research. Improvements in neuropathic symptom scores and functional measures in small‑fiber neuropathy cohorts Objective increases in small‑fiber metrics (e.g., corneal nerve fiber parameters) in some studies...